GILEAD SCIENCES INC's ticker is and the CUSIP is 375558AP8. A total of 69 filers reported holding GILEAD SCIENCES INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $55,270,000 | -9.6% | 13,471,000 | -0.4% | 0.37% | -5.4% |
| Q4 2015 | $61,136,000 | -1.3% | 13,531,000 | -5.4% | 0.39% | -9.1% |
| Q3 2015 | $61,916,000 | -16.2% | 14,298,000 | -0.2% | 0.43% | -6.6% |
| Q2 2015 | $73,929,000 | +12.7% | 14,333,400 | -5.9% | 0.46% | +11.2% |
| Q1 2015 | $65,589,000 | -11.9% | 15,233,400 | -15.3% | 0.41% | -16.6% |
| Q4 2014 | $74,483,000 | -42.6% | 17,983,000 | -35.0% | 0.49% | -43.0% |
| Q3 2014 | $129,662,000 | -1.9% | 27,678,000 | -23.4% | 0.86% | +3.2% |
| Q2 2014 | $132,211,000 | +14.5% | 36,156,000 | -2.7% | 0.84% | +13.6% |
| Q1 2014 | $115,420,000 | -14.7% | 37,174,000 | -9.4% | 0.74% | -14.2% |
| Q4 2013 | $135,290,000 | +7.1% | 41,011,000 | -10.3% | 0.86% | +8.6% |
| Q3 2013 | $126,337,000 | +2.6% | 45,705,000 | -14.9% | 0.79% | -1.5% |
| Q2 2013 | $123,078,000 | – | 53,732,000 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INCOME RESEARCH & MANAGEMENT | 9,376,000 | $40,393,000 | 6.90% |
| MACKAY SHIELDS LLC | 12,148,000 | $52,358,000 | 2.77% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,500,000 | $6,465,000 | 2.53% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 6,200,000 | $26,710,000 | 2.53% |
| SSI INVESTMENT MANAGEMENT LLC | 4,620,000 | $19,905,000 | 1.88% |
| CNO Financial Group, Inc. | 500,000 | $2,154,000 | 0.91% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 13,789,000 | $59,376,000 | 0.86% |
| Man Investments (CH) AG | 400,000 | $1,724,000 | 0.83% |
| Lombard Odier Asset Management (Europe) Ltd | 2,380,000 | $10,242,000 | 0.80% |
| CQS Cayman LP | 3,750,000 | $16,252,000 | 0.76% |